Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
Public ClinicalTrials.gov record NCT00549770. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Range Study to Evaluate the Efficacy and Safety of LCZ696 Comparatively to Valsartan, and to Evaluate AHU377 to Placebo After 8 Week Treatment in Patients With Essential Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study was a dose-ranging efficiacy study in patients with essential hypertension to assess the blood pressure lowering effect, and safety of LCZ696 compared to valsartan and placebo. The study will also evaluate the efficacy and safety of AHU377 as compared to placebo.
Study identification
- NCT ID
- NCT00549770
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 1,334 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2007 (Type not available)
- Primary completion
- Jul 2008 (Actual)
- Completion
- Jul 2008 (Actual)
- Last update posted
- Aug 25, 2015
2007 – 2008
United States locations
- U.S. sites
- 38
- U.S. states
- 17
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Birmingham | Alabama | 35294-2041 | — |
| Novartis Investigative Site | Muscle Shoals | Alabama | 35662 | — |
| Novartis Investigative Site | Chandler | Arizona | 85224 | — |
| Novartis Investigative Site | Buena Park | California | 90620 | — |
| Novartis Investigative Site | Fair Oaks | California | 95628 | — |
| Novartis Investigative Site | Long Beach | California | 90806 | — |
| Novartis Investigative Site | Los Angeles | California | 90057 | — |
| Novartis Investigative Site | Orangevale | California | 95662 | — |
| Novartis Investigative Site | Santa Ana | California | 92701 | — |
| Novartis Investigative Site | Stockton | California | 95204 | — |
| Novartis Investigative Site | Tustin | California | 92780 | — |
| Novartis Investigative Site | Jacksonville | Florida | 32216 | — |
| Novartis Investigative Site | Pembroke Pines | Florida | 33024 | — |
| Novartis Investigative Site | Pembroke Pines | Florida | 33029 | — |
| Novartis Investigative Site | Pensacola | Florida | 32504 | — |
| Novartis Investigative Site | Augusta | Georgia | 30904 | — |
| Novartis Investigative Site | Chicago | Illinois | 60607 | — |
| Novartis Investigative Site | Chicago | Illinois | 60610 | — |
| Novartis Investigative Site | Peoria | Illinois | 61615 | — |
| Novartis Investigative Site | Baton Rouge | Louisiana | 70809 | — |
| Novartis Investigative Site | Metairie | Louisiana | 70006 | — |
| Novartis Investigative Site | Chelsea | Michigan | 48118 | — |
| Novartis Investigative Site | Royal Oak | Michigan | 48073 | — |
| Novartis Investigative Site | Brooklyn Center | Minnesota | 55430-2168 | — |
| Novartis Investigative Site | City of Saint Peters | Missouri | 63376 | — |
| Novartis Investigative Site | Toms River | New Jersey | 08753 | — |
| Novartis Investigative Site | Trenton | New Jersey | 08629 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45219 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45224 | — |
| Novartis Investigative Site | Oklahoma City | Oklahoma | 73132-4904 | — |
| Novartis Investigative Site | Simpsonville | South Carolina | 29681 | — |
| Novartis Investigative Site | Dallas | Texas | 75235 | — |
| Novartis Investigative Site | Houston | Texas | 77030-3411 | — |
| Novartis Investigative Site | Houston | Texas | 77081 | — |
| Novartis Investigative Site | Houston | Texas | 77083 | — |
| Novartis Investigative Site | Lake Jackson | Texas | 77566 | — |
| Novartis Investigative Site | Richmond | Virginia | 23294 | — |
| Novartis Investigative Site | Charleston | West Virginia | 25301 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 144 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00549770, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2015 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00549770 live on ClinicalTrials.gov.